66 results
8-K
EX-99.1
ELDN
Eledon Pharmaceuticals Inc
2 Nov 23
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
4:30pm
in the study. There were no cases of graft loss or death.
Aggregate mean estimated glomerular filtration rate (eGFR) – a measure of kidney function
8-K
EX-99.2
1s9r4cyax6vx wq4wcv
2 Nov 23
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
4:30pm
8-K
nf87kbeug6dzszj
21 Jun 23
Departure of Directors or Certain Officers
7:51pm
8-K
EX-10.1
qrdbwycxc7 wkwc7qhe
21 Jun 23
Departure of Directors or Certain Officers
7:51pm
8-K
EX-99.2
q5hhondg ujzqrxta
31 May 22
Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart
6:38am